Effects of hirudotherapy on liver functions, lipid profile, and insulin sensitivity in rats with metabolic syndrome
Basic science / preclinical published in BMC complementary medicine and therapies (2026)
Abstract
BACKGROUND: Metabolic syndrome (METS) is a multifactorial cardiometabolic disorder characterized by abdominal obesity, insulin resistance, hypertension, dyslipidemia, and hyperglycemia, substantially increasing the risk of type 2 diabetes and cardiovascular diseases. The variable effectiveness of lifestyle and pharmacological interventions has heightened interest in complementary approaches. Hirudotherapy, containing a wide range of bioactive compounds, may offer therapeutic benefits. This study aimed to evaluate the effects of hirudotherapy on metabolic parameters in a rat model of METS. METHODS: Twenty-four male Wistar rats were divided into four groups: Control (n = 6), METS (n = 6), METS + 4-week hirudotherapy (n = 6), and METS + 8-week hirudotherapy (n = 6). METS was induced through a modified high-fat and fructose-enriched diet. The effects of hirudotherapy on liver enzymes (AST, ALT), lipid profile (TG, LDL cholesterol, HDL cholesterol), hemodynamic parameters (systolic/diastolic blood pressure, mean arterial pressure, heart rate), glucose metabolism (OGTT, AUC), and liver histopathology were assessed. Pellet and water intake were monitored to evaluate possible influences on appetite regulation. RESULTS: Hirudotherapy demonstrated hepatoprotective activity, yielding significant reductions in AST and ALT levels (p < 0.05). TG levels increased in METS, while LDL cholesterol showed partial improvement and HDL cholesterol remained unchanged. Systolic blood pressure significantly decreased in the hirudotherapy-treated groups, with no significant differences in diastolic pressure or heart rate. OGTT and AUC analyses revealed improved glucose tolerance and reduced hyperglycemia following hirudotherapy (p < 0.05). Histopathology showed marked improvements in steatosis, sinusoidal dilatation, and hydropic degeneration, although minor hemorrhagic foci persisted. Differences in pellet consumption suggested a potential regulatory effect on appetite and metabolic balance. CONCLUSION: Hirudotherapy may exert beneficial effects in METS by improving liver function, modulating lipid metabolism, enhancing insulin sensitivity, and reducing inflammation. Its influence on food intake may further support metabolic homeostasis. These findings support hirudotherapy as a potential biotherapeutic approach and warrant further mechanistic and clinical investigations.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Metabolic syndrome (METS) is a multifactorial cardiometabolic disorder characterized by abdominal obesity, insulin resistance, hypertension, dyslipidemia, and hyperglycemia, substantially increasing the risk of type 2 diabetes and cardiovascular diseases.
Por qué esto importa para la hirudoterapia
Este estudio indujo síndrome metabólico en ratas Wistar macho con una dieta alta en grasas y enriquecida con fructosa, y aplicó hirudoterapia durante 4 u 8 semanas, reportando reducciones significativas en las enzimas hepáticas AST y ALT, disminución de la presión arterial sistólica, mejora en la tolerancia a la glucosa en el OGTT y mejora histológica en la esteatosis hepática (p < 0.05), mientras que los triglicéridos aumentaron y el HDL no experimentó cambios. Para ASH, este es uno de los intentos más sistemáticos para investigar si el secretoma de la sanguijuela actúa sobre objetivos cardiometabólicos más allá de la anticoagulación local, sugiriendo posibles efectos hepatoprotectores y sensibilizadores a la insulina que merecen un seguimiento mecanístico. La advertencia honesta es que se trata de un pequeño experimento animal preclínico (seis ratas por grupo) en un modelo de enfermedad inducida; no puede establecer la eficacia o seguridad en humanos, y los propios autores solicitan una mayor investigación mecanística y clínica.
Citación
Effects of hirudotherapy on liver functions, lipid profile, and insulin sensitivity in rats with metabolic syndrome.
Bilden A et al. · BMC complementary medicine and therapies, 2026
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: March 18, 2026 · Última actualización del sitio: June 18, 2026